Grünenthal is Recognized for its Strong Management of Environmental, Social and Governance (ESG) Risks

  • Main world ESG rankings company Sustainalytics notes Grünenthal is within the best 5 p.c amongst its friends within the pharmaceutical subindustry
  • Grünenthal is classified as “medium possibility”, striking it forward of its key subindustry friends and in the similar league as multinational firms like Pfizer and Roche

Aachen, Germany, 7 April 2021 – Grünenthal, an international science-based pharmaceutical corporate, nowadays introduced that Sustainalytics, a Morningstar corporate and a globally-recognized supplier of ESG analysis, rankings and information, has assessed it as having total medium ESG possibility. As well as, Sustainalytics said that Grünenthal has a powerful control of its ESG dangers. This puts Grünenthal within the best 5 p.c of the worldwide prescribed drugs subsector.

“The long-term good fortune of businesses can now not be measured by means of monetary good fortune on my own. As a science-based corporate, Grünenthal strives to make a net-positive have an effect on at the society,” mentioned Gabriel Baertschi, CEO Grünenthal. “Whilst we’re proud to look our efforts identified on this ESG ranking, we all know that a large a part of the adventure remains to be forward folks. Development on our basis as a accountable trade, we will be able to now combine sustainability much more carefully in our core technique.”

Grünenthal used to be evaluated by means of Sustainalytics according to its ESG Possibility Rankings framework, which specializes in publicity and control of an organization’s subject matter ESG problems. “Publicity” displays the stage to which an organization’s endeavor worth is uncovered to subject matter ESG problems together with moral advertising and marketing, medical trial transparency, whistleblowing, corruption and bribery. “Control” measures an organization’s preparedness and monitor report in managing its publicity to subject matter ESG problems via its insurance policies, programmes, trainings and control methods.

The corporate’s ESG Possibility Score is to be had on Sustainalytics’ website online. All information discussed is as of 6 April 2021 and consult with the Grünenthal Pharma GmbH & Co. KG.

About Grünenthal’s ESG efforts
Grünenthal has been focusing its Environmental, Social & Governance (ESG) efforts on 4 pillars: train about ache remedy and accountable use of opioids; make sure that get right of entry to to drugs, innovate ache control, and lift consciousness for “ache as a illness”:

Train about ache remedy and accountable use of opioids
Grünenthal has up to now reached round 65,000 well being care execs in its efforts to teach the healthcare sector about ache control and support the affected person results from ache remedy. As a pace-setter in ache innovation and as an opioid producer, Grünenthal is very dedicated to making sure that its staff, shoppers, sufferers and likewise its companions have a radical figuring out of the corporate’s stance at the accountable clinical use of opioids in ache. The corporate has fostered a mindset shift alongside the overall worth chain by means of making sure that every one opioid-related fabrics include Grünenthal’s remark on accountable use of opioids – obviously highlighting the dangers and advantages of this magnificence of medications. As well as, Grünenthal had established a devoted status governance frame to supply and advertise transparent steering, coherent habits, steady growth, coaching and keep an eye on mechanisms.

Be sure get right of entry to to drugs
Grünenthal is dedicated to making sure the supply of key drugs to deal with unmet clinical wishes within the markets we serve. In america, for example, five million sufferers are wanting neuropathic ache remedy related to diabetes. With america FDA label extension of one in all our non-opioid ache drugs for the remedy of neuropathic ache related to diabetic peripheral neuropathy of the ft, Grünenthal has ensured sufferers get get right of entry to to this a lot wanted remedy. On the identical time, the corporate is all for addressing unmet healing wishes in underserved markets by means of providing specialised non-opioid ache drugs.

Innovate ache control
Grünenthal’s analysis and building technique specializes in tackling in ache and taking part with companions to deal with the massive unmet wishes in ache. Thru biennial grants of €200,000 equipped by means of Grünenthal and the EFIC, the corporate helps younger scientists early of their profession in sporting out leading edge medical ache analysis. Since basis of the EFIC-Grünenthal Grant in 2004, roughly €1.6 million used to be awarded to fund 65 tasks. As well as, to force patient-centric innovation in power ache and neurological problems and award patient-centric and scientifically tough innovation, the corporate helps the Mind, Thoughts, and Ache Affected person-Targeted Innovation Grant, which awards €90,000 biennially to analyze proposals to inspire patient-centered innovation that results in enhancements within the lifestyles prerequisites of ache sufferers.

Lift consciousness for “ache as a illness”
Persistent ache is a gigantic world well being downside affecting round 10% of the arena’s inhabitants. Grünenthal raises consciousness concerning the have an effect on of ache by means of supporting a multi-stakeholder platform, known as the Societal Affect of Ache platform, which fosters the advance of ache insurance policies on nationwide stage. With Grünenthal’s Ache Toolkit, the corporate has established a sensible device that gives sufferers with at hand pointers and talents within the type of explanations, infographics and movies, on methods to self-manage ache. Additionally, Grünenthal has a long-standing hobby for maintaining the respect and high quality of lifestyles on the finish degree of other folks’s lives. The Grünenthal Basis for Palliative Care promotes science and analysis in palliative care and the handle critically or terminally sick other folks in Europe in addition to in Latin The united states.

But even so those 4 center of attention pillars, Grünenthal is protecting all of the vary of the Environmental, Social and Governance spectrum with quite a lot of tasks and measures:

Our efforts to advertise sustainable building come with defining concrete objectives for the operations of our 5 manufacturing websites, throughout our provide chain and all of our associates around the globe by means of following main world requirements for atmosphere, well being and protection. We accumulate and analyze information from our manufacturing websites and use it to ceaselessly support potency, whilst additionally decreasing power intake and minimizing waste according to strategic way of 0 waste to landfill programme.

Taking good care of its staff and for the communities the place we function is essential to Grünenthal’s trade behavior. Grünenthal be offering its staff a thrilling running atmosphere and wide-ranging person building alternatives. It’s the corporate’s objective to take care of excessive ranges of engagement and to enhance the corporate as a Nice Position to Paintings®. Grünenthal promotes a colourful, high-performance tradition and brings it to reside via a shared set of values. Those are supported by means of explicit behaviours that information the decision-making. Grünenthal guarantees exceptional effects are recognised and rewarded. As an example, the corporate celebrates outstanding contributions each and every yr with its Grünenthal International Excellence Award.

Sound governance is essential to safeguard the corporate’s license to function and proceed offering drugs to sufferers in want. Grünenthal has a complete compliance and ethics control device which supplies a transparent framework for our choices and movements. Grünenthal’s Code of Behavior for staff reiterates the corporate’s sturdy dedication to the easiest moral requirements whilst the Code of Behavior for Trade Companions guarantees trade relationships according to a reciprocal dedication to accountable habits. Grünenthal has an exterior Ethics Helpline for 24/7 nameless reporting in position to make sure compliance with the Code of Behavior. Grünenthal may be dedicated to complete disclosure of transfers of worth to healthcare execs, healthcare organizations and affected person organizations.

About Grünenthal
Grünenthal is an international chief in ache control and connected illnesses. As a science-based, privately-owned pharmaceutical corporate, we’ve a protracted monitor report of bringing leading edge remedies and cutting-edge applied sciences to sufferers international. Our function is to switch lives for the simpler – and innovation is our hobby. We’re focussing all of our actions and efforts on running against our imaginative and prescient of an international freed from ache.

Grünenthal is headquartered in Aachen, Germany, and has associates in 29 international locations throughout Europe, Latin The united states and america. Our merchandise are to be had in additional than 100 international locations. In 2020, Grünenthal hired round four,500 other folks and completed gross sales of € 1.three bn.

Additional info:

Practice us on:
LinkedIn: Grunenthal Workforce
Instagram: grunenthal

For additional data, please touch:
Florian Dieckmann, Head International Communications, +49 241 569 2555,

Fabia Kehren, Head Exterior Communications & Editorial Control,
+49 241 569-3269

Grünenthal GmbH, 52099 Aachen, Germany

Leave a Reply

Your email address will not be published. Required fields are marked *